Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit
09:14am, Tuesday, 11'th Jan 2022
Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.
Should You Invest in the VanEck Biotech ETF (BBH)?
11:20am, Monday, 10'th Jan 2022 Zacks Investment Research
Sector ETF report for BBH
Should You Invest in the VanEck Biotech ETF (BBH)?
07:42am, Monday, 10'th Jan 2022
Sector ETF report for BBH
Biotech M&A Could Finally Perk Up in 2022
02:52pm, Monday, 27'th Dec 2021
Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, ma
VanEck Vectors Biotech ETF (NASDAQ:BBH) Position Increased by Mogy Joel R Investment Counsel Inc.
03:20pm, Tuesday, 14'th Dec 2021 Dakota Financial News
Mogy Joel R Investment Counsel Inc. raised its holdings in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) by 5.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 31,036 shares of the company’s stock after purchasing an additional 1,619 shares during […]
Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends
07:35am, Thursday, 09'th Dec 2021
We cover dividend stocks often at 24/7, as they provide investors with much better income streams than U.S.
Bet on BBH for Biotechnology Bounce Back
01:16pm, Wednesday, 08'th Dec 2021
Biotechnology equities are lagging the healthcare sector and the broader market this year, but with new variants of the coronavirus expected to continue popping up in 2022, it's impossible to ignore b
Smaller Biotech Stocks Ready to Perk Up
10:45am, Tuesday, 07'th Dec 2021
If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more re
Top ETF Stories of November
06:00pm, Wednesday, 01'st Dec 2021 Zacks Investment Research
The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.
Top ETF Stories of November
02:33pm, Wednesday, 01'st Dec 2021
The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.
Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron
05:57pm, Tuesday, 30'th Nov 2021 Zacks Investment Research
Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.
BBH: Better Than IBB For Covid Exposure Including The Omicron Variant
02:25pm, Tuesday, 30'th Nov 2021
The relatively less known VanEck's BBH has delivered a better one-year performance than the popular iShares' IBB.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
06:00pm, Monday, 29'th Nov 2021 Zacks Investment Research
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
02:36pm, Monday, 29'th Nov 2021
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
VanEck Vectors Biotech ETF (NASDAQ:BBH) Shares Gap Up to $192.41
05:14pm, Friday, 26'th Nov 2021 Dakota Financial News
VanEck Vectors Biotech ETF (NASDAQ:BBH)s share price gapped up before the market opened on Friday . The stock had previously closed at $192.41, but opened at $198.91. VanEck Vectors Biotech ETF shares last traded at $198.91, with a volume of 100 shares. The firms 50-day moving average price is $197.80 and its two-hundred day moving []
